As CK Science has earlier reported, here, GSK is set to expand its UK operations, adding to the current 16,000 employees throughout Britain. Two sites in Scotland and one in county Durham are being looked into as locations to create new plants. This comes at a time when other companies with UK branches are scaling back their operations. Andrew Witty, GSK’s chief executive, has said that his company wants to “have more manufacturing and do more R&D work in Britain” leading to a greater amount of tax paid by GSK.
In the next few years, GSK expects to be a “net hirer” because the UK can strike a good balance between research and development support and competitive medicine prices. GSK has moved back into the black this year, recording a £1.1 billion profit in the second quarter, meaning that they can afford the expense of reopening UK operations.
Looking for a job in the science industry? Start by clicking here, now